TAVR and SAVR: Current Treatment of Aortic Stenosis

Abstract

Transcatheter aortic valve replacement (TAVR) was approved in the United States in late 2011, providing a critically needed alternative therapy for patients with severe aortic stenosis previously refused surgical aortic valve replacement (SAVR). Over 20,000 TAVR have been performed in patients worldwide since 2002 when Alain Cribier performed the first-in… (More)
DOI: 10.4137/CMC.S7540

Topics

12 Figures and Tables